Detalhe da pesquisa
1.
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med
; 384(9): 829-841, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33657295
2.
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.
Cancer Immunol Immunother
; 73(8): 142, 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38832989
3.
Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell Carcinoma.
Oncologist
; 28(1): 72-79, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124890
4.
Erdafitinib in the Treatment of Metastatic Urothelial Carcinoma.
Oncology (Williston Park)
; 37(6): 256-261, 2023 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37343207
5.
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(7): 888-898, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688173
6.
Metastatic Renal Cell Carcinoma With Sarcomatoid Features.
Oncology (Williston Park)
; 36(4): 221-225, 2022 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35436063
7.
Oncofertility Knowledge Among Internal Medicine Residents in an Academic Center in Mexico.
J Cancer Educ
; 37(1): 10-15, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32462498
8.
Patient Navigation to Improve Early Access to Supportive Care for Patients with Advanced Cancer in Resource-Limited Settings: A Randomized Controlled Trial.
Oncologist
; 26(2): 157-164, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33210345
9.
Hand-Foot Skin Reaction Secondary to Sunitinib in a Patient With Metastatic Clear Cell Renal Cell Carcinoma.
Oncology (Williston Park)
; 35(5): 272-276, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33998784
10.
A View from the past into our collective future: the oncofertility consortium vision statement.
J Assist Reprod Genet
; 38(1): 3-15, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33405006
11.
CHALLENGES OF TREATING YOUNG WOMEN WITH CANCER IN THE ERA OF NEW ONCOLOGIC TREATMENTS.
Rev Invest Clin
; 73(5): 302-305, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34609370
12.
Outcomes and Challenges of Reproductive Health in Hematopoietic Stem Cell Transplantation Survivors.
Biol Blood Marrow Transplant
; 26(11): 2127-2131, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32659435
13.
Latent Tuberculosis in Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Strategies to Prevent Disease Activation in an Endemic Population.
Biol Blood Marrow Transplant
; 26(7): 1350-1354, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32200119
14.
Immunosenescence profile and expression of the aging biomarker (p16INK4a) in testicular cancer survivors treated with chemotherapy.
BMC Cancer
; 20(1): 882, 2020 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32928147
15.
69-Year-Old Man With Castration-Resistant Prostate Cancer Progressing After Docetaxel and Androgen Receptor-Targeting Agent.
Oncology (Williston Park)
; 34(4)2020 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32293692
16.
Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab.
Oncology (Williston Park)
; 34(5): 171-174, 2020 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32644176
17.
Disorders of Sex Development and Malignant Germ Cell Tumors.
Oncology (Williston Park)
; 34(10): 421-426, 2020 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33058108
18.
Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic.
Oncology (Williston Park)
; 34(8): 317-319, 2020 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785928
19.
Women, power, and cancer: a Lancet Commission.
Lancet
; 402(10417): 2113-2166, 2023 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37774725
20.
Multiple Myeloma With Extramedullary Disease: A Challenging Clinical Dilemma.
Oncology (Williston Park)
; 33(4): 149-51, 155, 2019 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30990568